Tirzepatide alone achieves 20.9% weight loss in SURMOUNT-1, which approaches or matches what phentermine-plus-semaglutide combinations achieve in observational data
Nausea was reported in 57% of patients receiving semaglutide and 7% receiving placebo
Ideal Candidates for Semaglutide Treatment Consider joining the semaglutide weight loss program if you have a BMI of 30 or higher, or a BMI of 27 or higher with related medical conditions like high blood pressure, type 2 diabetes, or high cholesterol
Nutrition and neurotransmitters: the nutrient bases of behavior
PlexusDx specializes in helping patients maintain their progress through affordable, customized peptide protocols
They differ by approved indication, dosing, and formulation